Riskpilot← Back to searchSign inGet full accessVSA Innovation AB
ABActiveOrg 5592413826Medicinaregatan 8 AManufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20200 employees
Revenue 2025
SEK -2
EBITDA margin
1567950.0%
+45% vs 2024
Equity ratio
73.5%
Financial strength
Net profit 2025
SEK -53K
+26% vs 2024
| Revenue | SEK -2 | — |
| EBITDA | SEK -31K | +45% |
| Net profit | SEK -53K | +26% |
| Total assets | SEK 820K | +0% |
| Equity | SEK 602K | -8% |
| Employees | 0 | — |
Legal name
VSA Innovation AB
Org number
5592413826
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
10 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget utvecklar och kommersialserar lösningar som möjliggör digitalisering av vård. Visionen bakom bolagets produkter är att fler människor skall ha möjligheten att digitalt följa sin hälsostatus. Bolagets lösningar förbättrar också arbetseffektivteten och produktiviteten inom hälso- och sjukvård.
Address
Medicinaregatan 8 A
Email
liupeidi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | −0 | 0 | 0 | −0 |
| Staff expenses | — | — | — | −3 | −0 |
| EBITDA | −101 | −172 | −27 | −57 | −31 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −101 | −172 | −27 | −57 | −31 |
| Net financials | — | — | — | −14 | −21 |
| Profit before tax | −101 | −172 | −27 | −71 | −53 |
| Tax | −0 | — | — | — | — |
| Net profit | −101 | −172 | −27 | −71 | −53 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 78 | 83 | 686 | 821 | 820 |
| Equity | 78 | 83 | 686 | 655 | 602 |
| Long-term debt | 0 | — | — | 157 | 157 |
| Short-term debt | 0 | — | — | 9 | 60 |
| Total debt | — | — | — | 166 | 217 |
EBITDA margin
-3135900.0%
This company
15.8%
Market median
-19847568% vs market
20212025
Equity ratio
73.5%
This company
38.2%
Market median
+92% vs market
20212025
Return on equity
-8.7%
This company
18.4%
Market median
-147% vs market
20212025
Net profit margin
-5267200.0%
This company
8.1%
Market median
-65027260% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VSA Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pengzhi Zhou | Board of Directors | 0 companies |
| Peidi Liu | Board of Directors | 0 companies |
| Marouane Bousfiha | Deputy Board Member | 0 companies |
| Supakarn Ned Phatcharasophon | Board of Directors | 0 companies |